Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.

[1]  P. Kumar,et al.  Vicryl carrier for I-125 seeds: percutaneous transperineal insertion. , 1986, Radiology.

[2]  M Wannenmacher,et al.  Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. , 1988, International journal of radiation oncology, biology, physics.

[3]  A. Steinfeld,et al.  Pulmonary embolization of iodine-125 seeds following prostate implantation. , 1991, Urology.

[4]  S Nag,et al.  Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.

[5]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[6]  Haakon Ragde.  How I do it: Brachytherapy (seed implantation) for clinically localized prostate cancer , 1997 .

[7]  S Nag,et al.  Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[8]  T W Griffin,et al.  Reduction of radioactive seed embolization to the lung following prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[9]  B. Davis,et al.  Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. , 2000, The Journal of urology.

[10]  W. Butler,et al.  Seed fixity in the prostate/periprostatic region following brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[11]  S Nag,et al.  Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations. , 2000, Seminars in urologic oncology.

[12]  M. Resnick,et al.  Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[13]  T. Krupski,et al.  Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. , 2001, The Journal of urology.

[14]  T. P. Cooper,et al.  2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. , 2002, The Journal of urology.

[15]  B. Davis,et al.  Prostate brachytherapy seed migration to a coronary artery found during angiography. , 2002, The Journal of urology.

[16]  Weichung Joe Shih,et al.  Implications of radioactive seed migration to the lungs after prostate brachytherapy. , 2002, Urology.

[17]  M. Resnick,et al.  Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma. , 2003, Brachytherapy.

[18]  M. Resnick,et al.  Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma. , 2003, International journal of radiation oncology, biology, physics.

[19]  I. Kaplan,et al.  A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial. , 2004, Brachytherapy.

[20]  Ann L Oberg,et al.  Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration. , 2004, International journal of radiation oncology, biology, physics.

[21]  J. Koziol,et al.  Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. , 2004, Brachytherapy.

[22]  Dan Ash,et al.  The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.